GC
NVS icon

Gratry & Company’s Novartis NVS Stock Holding History

Gratry & Company’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-23,483
Closed -$1.52M – 79
2016
Q1 		$1.52M Sell
23,483
-37,108
-61% -$2.52M 1.09% 33
2015
Q4 		$4.67M Sell
60,591
-2,685
-4% -$213K 3.04% 18
2015
Q3 		$5.21M Sell
63,276
-34
-0.1% -$3.03K 3.2% 13
2015
Q2 		$5.58M Buy
63,310
+3,443
+6% +$316K 2.92% 21
2015
Q1 		$5.29M Sell
59,867
-55,867
-48% -$4.96M 2.86% 19
2014
Q4 		$8.34M Buy
115,734
+35,459
+44% +$2.94M 2.73% 13
2014
Q3 		$6.77M Sell
80,275
-18,337
-19% -$1.48M 3.55% 6
2014
Q2 		$8M Sell
98,612
-11,150
-10% -$877K 3.15% 9
2014
Q1 		$8.36M Sell
109,762
-5,972
-5% -$435K 3.01% 11
2013
Q4 		$8.34M Sell
115,734
-849
-0.7% -$59K 2.73% 13
2013
Q3 		$8.01M Buy
116,583
+960
+0.8% +$63.5K 2.83% 10
2013
Q2 		$7.33M Buy
+115,623
New +$7.52M 2.85% 9

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Gratry & Company's NVS Position: Q2 2016 in Review

Gratry & Company sold out of Novartis (NVS) in Q2 2016, closing a stake of 23,483 shares — an estimated $1.52M sold.

Gratry & Company first reported a position in NVS in Q2 2013 and held it in 12 quarters. The position peaked at $8.36M in Q1 2014. 878 funds tracked by Wall St. Rank hold NVS as of Q2 2016.

  • Gratry & Company reported no remaining Novartis position as of Q2 2016 after selling out during the quarter.
  • Gratry & Company sold 23,483 Novartis shares in Q2 2016, an estimated $1.52M.
  • Gratry & Company first reported a position in Novartis in Q2 2013 and held it in 12 quarters.
  • Gratry & Company's Novartis position peaked at $8.36M in Q1 2014.
  • 878 funds tracked by Wall St. Rank held Novartis as of Q2 2016.

Based on Gratry & Company's 13F filing for Q2 2016, filed 10 Aug 2016.